Design and discovery of new 1,2,4‐triazolo[4,3‐ c ]quinazolines as potential DNA intercalators and topoisomerase II inhibitors-Reference-Cited by-同舟云学术

Design and discovery of new 1,2,4‐triazolo[4,3‐ c ]quinazolines as potential DNA intercalators and topoisomerase II inhibitors

Published:2020-11-23 Issue:3 Volume:354 Page:2000237
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch Pharm

Author:

Alesawy Mohamed S.¹^ORCID,Al‐Karmalawy Ahmed A.²^ORCID,Elkaeed Eslam B.³^ORCID,Alswah Mohamed³,Belal Ahmed⁴^ORCID,Taghour Mohammed S.¹,Eissa Ibrahim H.¹^ORCID

Affiliation:

1. Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys) Al‐Azhar University Cairo Egypt

2. Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy Horus University‐Egypt New Damietta Egypt

3. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys) Al‐Azhar University Cairo Egypt

4. Zoology Department, Faculty of Science Al‐Azhar University Cairo Egypt

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.202000237

Reference66 articles.

1. Cancer Statistics, 2005

2. WHO Cancer Key facts https://www.who.int/news-room/fact-sheets/detail/cancer (accessed: October 2019).

3. DNA and its associated processes as targets for cancer therapy

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palladium‐Catalyzed Three‐Component Process to [1,2,3]Triazolo [1,5‐c]quinazolines;ChemistrySelect;2024-07

2. Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators;Archiv der Pharmazie;2024-06-12

3. Exploring Anticancer Potential: Synthesis and Assessment of the Biological Activity of Novel Synthesized Pyrazinoic Acid Derivatives;ChemistrySelect;2024-05-15

4. Quinazolines annelated at the N(3)–C(4) bond: Synthesis and biological activity;European Journal of Medicinal Chemistry;2024-05

5. Exploring new quinazolin‐4(3H)‐one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation;Drug Development Research;2024-02-28